Response Genetics (RGDX) Reports Q4 Loss of $0.09/Share

Response Genetics (NASDAQ: RGDX) reported Q4 EPS of ($0.09), versus ($0.06) reported last year. Revenue for the quarter came in at $4.1 million, versus $4.8 million reported last year.

For earnings history and earnings-related data on Response Genetics (RGDX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c